New virtual therapy aims to ease anxiety in TNBC survivors
NCT ID NCT07513311
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether a nurse-led, group-based virtual coping program called RESTORE is feasible and acceptable for people who have finished treatment for triple-negative breast cancer. The program teaches skills like problem-solving, relaxation, and mindfulness to help reduce anxiety and fear of cancer recurrence. Researchers will enroll 75 participants to see if they stick with the program and find it helpful.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RESTORE (nurse-led virtual cognitive-behavioral therapy-based intervention)
What this could lead to
If successful, this program could provide a practical, scalable way to help TNBC survivors manage anxiety and improve their quality of life after treatment.
What could go wrong
This is a small pilot study focused on feasibility, not on proving the program works. It may not show meaningful improvements in distress or quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER (TNBC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02144, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact